60 DEGREES PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-18.2M | $115.4K |
| FY2022 | — | $-23.6M | $264.9K |
| FY2023 | $150.0K | $4.9M | $2.1M |
| FY2024 | $147.1K | $4.0M | $1.7M |
| FY2025 | $144.0K | $3.5M | $1.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-18.2M | $115.4K |
| FY2022 | — | $-23.6M | $264.9K |
| FY2023 | $150.0K | $4.9M | $2.1M |
| FY2024 | $147.1K | $4.0M | $1.7M |
| FY2025 | $144.0K | $3.5M | $1.5M |